Acadia - International Biopharmaceutical Industry

Current Edition

news

FDA panel to review once-rejected Acadia drug for psychosis

Dive Brief: After receiving a rejection last year, Acadia said Wednesday that the Food and Drug Administration agreed to review its resubmitted application to expa...

14 March 2022 news Acadia | Alzheimer

Continue Reading →

news

Acadia shares rise on study success for Rett syndrome drug

No treatments are available for Rett syndrome, although a number of companies, including Acadia, aim to change that. Acadia's drug is a synthetic version of a protei...

10 December 2021 news Acadia | brain development

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

FDA panel to review once-rejected Acadia drug for psychosis

Acadia shares rise on study success for Rett syndrome drug

International Biopharmaceutical Industry